Aytu BioPharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	22.99	19.36	49.9	48.33	11.29	7.11	0.88	8.05	7.36	2.64
Short-Term Investments	0	0	0	0	0	0	0	1.04	0	0
Cash & Cash Equivalents	22.99	19.36	49.9	48.33	11.29	7.11	0.88	9.1	7.36	2.64
Cash Growth	18.72%	-61.20%	3.24%	327.94%	58.79%	710.51%	-90.35%	23.62%	178.75%	-
Receivables	28.94	21.71	28.18	5.63	1.74	0.58	0.53	0.16	0.16	0
Inventory	12	10.85	16.34	10	1.44	1.34	1.31	0.52	0.04	0
Other Current Assets	8.92	8.01	10.82	11.46	0.96	0.44	0.31	0.34	0.49	0.66
Total Current Assets	72.83	59.93	105.23	75.42	15.43	9.47	3.03	10.12	8.04	3.3
Property, Plant & Equipment	3.87	6.3	8.7	0.89	0.2	0.22	0.65	0.23	0.03	0.06
Long-Term Investments	0	0	0	0	0	0.01	0	0	0	0
Goodwill and Intangibles	58.97	70.63	151.27	76.95	19.08	11.37	11.32	13.77	2.27	0.7
Other Long-Term Assets	0.79	0.77	0.47	0.03	0	0	0	0.21	7.84	7.96
Total Long-Term Assets	63.63	77.69	160.43	77.87	19.29	11.59	11.97	14.22	10.14	8.71
Total Assets	136.46	137.62	265.67	153.29	34.72	21.06	15	24.34	18.19	12.02
Accounts Payable	13.48	10.99	19.26	11.64	2.13	2.12	2.22	2.32	1.2	1.21
Deferred Revenue	0	0	0	0	0	0	0	0	0.51	0.6
Current Debt	1.65	3.91	24.6	1.28	0	0	0	5.38	0	4.6
Other Current Liabilities	53.89	49.55	65.58	15.84	3.24	1.28	1.39	2.4	-0.23	-0.32
Total Current Liabilities	69.02	64.44	109.44	28.76	5.37	3.39	3.61	10.1	1.48	6.09
Long-Term Debt	14.71	14.28	0.18	11.9	0	0	0	0	0	0
Other Long-Term Liabilities	13.38	14.59	18.48	17.62	22.26	4.24	7.39	4.15	1.09	0.55
Total Long-Term Liabilities	28.09	28.87	18.66	29.52	22.26	4.24	7.39	4.15	1.09	0.55
Total Liabilities	97.11	93.32	128.1	58.28	27.63	7.64	11	14.26	2.57	6.65
Total Debt	16.36	18.19	24.78	13.18	0	0	0	5.38	0	4.6
Debt Growth	-10.05%	-26.61%	88.04%	-	-	-	-	-	-	-
Retained Earnings	-304.13	-287.08	-178.3	-120.01	-106.39	-79.26	-69.07	-46.56	-18.38	-10.66
Shareholders' Equity	39.36	44.31	137.57	95.02	7.09	13.42	4	10.09	15.62	5.37
Net Cash / Debt	6.62	1.17	25.12	35.15	11.29	7.11	0.88	3.72	7.36	-1.96
Net Cash / Debt Growth	465.19%	-95.33%	-28.55%	211.26%	58.79%	710.51%	-76.38%	-49.50%	-	-
Net Cash Per Share	1.98	0.80	30.00	155.58	289.80	2137.18	376.63	168903.50	735794.70	-280050.00
Working Capital	3.82	-4.51	-4.2	46.66	10.06	6.08	-0.58	0.02	6.56	-2.79
Book Value Per Share	11.78	30.14	164.29	420.50	181.87	4033.78	1716.57	463391.52	1628070.48	741733.25

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).